Patent Expiry

Patent/Exclusivity Expiry: EVRYSDI

Other upcoming events for SRRK

Phase 2 StartPhase 2 Start: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, 52-Week Study Evaluating the E
Patent ExpiryPatent/Exclusivity Expiry: SPINRAZA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: EVRYSDI — SRRK Patent Expiry | BioSniper